Recruiting

NCT Number: NCT06223906

A Registry Study of Biomarkers in Heart Valve Disease

Valvular Heart Disease, impacting 2.5% of the population, is predominantly observed in the elderly and is on the rise. The primary conditions within this category are Aortic Stenosis and Mitral Regurgitation. These conditions are linked to considerable morbidity and mortality, presenting a formidable challenge in optimizing treatment strategies. Pathophysiology of Valvular Heart Disease remains poorly known. The aim of the present study is to identify biomarkers involved in this disease using multi-omics approaches

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Cardiovascular Diseases

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Beijing Anzhen Hospital

Beijing, Beijing Municipality, 100029, China

Location status: Recruiting

Location contact

Jie Du, PhD

PRINCIPAL_INVESTIGATOR

Yuan Wang, PhD

CONTACT

[email protected]

86-010-64456169

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients clinically diagnosed with heart valve disease in Beijing Anzhen Hospital

Exclusion criteria

Age < 18 years
Failure to obtain medical records and ultrasound data
Refuse follow-up

Treatment and study plan

Primary outcomes

All-cause death

Time frame: These data is collected during follow-up visit at 12 months after discharge

whether recidivation happened,whether other related disease happened

Secondary outcomes

HF rehospitalization

Time frame: These data is collected during follow-up visit at 12 months after discharge

heart failure related hospitalization within 1 years of discharge

Study contacts

Contact information is provided by the study sponsor or research team.

Rui Lin, Dr

CONTACT

[email protected]

15724230598

Yuan Wang, Dr

CONTACT

[email protected]

13910161443

Sponsors and collaborators

Lead sponsor

Beijing Institute of Heart, Lung and Blood Vessel Diseases

Other

Registry information

Acronym: BIOMS-HVD

Important dates

Study start: 2016
Primary completion: 2030
Study completion: 2030
First posted: Jan 25, 2024
Registry last updated: Jan 26, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting